Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01647906 · ClinicalTrials.gov registry record
Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
A clinical trial, sponsored by Bausch Health Americas.
- Completed
- Registry status
- 277
- Enrollment target
NCT01647906 is a clinical trial that has completed, run by Bausch Health Americas. The registered enrollment target is 277 participants.
The verdict
NCT01647906 has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- 277 participants
- Enrollment target
Study Summary
The purpose of this observational study is to evaluate the safety and effectiveness of the Solesta Injectable Bulking Agent in the treatment of fecal incontinence through 3 years in a real world setting.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 277 participants |
| Start Date | 2012-05-31 |
| Est. Completion | 2018-09-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01647906
The ClinicalTrials.gov registry entry for NCT01647906 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 277 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01647906 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01647906 about?
NCT01647906 is a clinical study titled "Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)". The purpose of this observational study is to evaluate the safety and effectiveness of the Solesta Injectable Bulking Agent in the treatment of fecal incontinence through 3 years in a real world setting.
What is the current status of trial NCT01647906?
This trial is currently completed. The enrollment target is 277 participants. The study started on 2012-05-31. Estimated completion is 2018-09-15.
Who is sponsoring clinical trial NCT01647906?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.